Cargando…
Philadelphia-Negative Myeloproliferative Neoplasms Around the COVID-19 Pandemic
PURPOSE OF REVIEW: Coronavirus disease 2019 (COVID-19) is associated with a high rate of respiratory failure, thromboembolism, bleeding, and death. Patients with myeloproliferative neoplasms (MPNs) are prone to both thrombosis and bleeding, calling for special care during COVID-19. We reviewed the c...
Autores principales: | Barbui, Tiziano, De Stefano, Valerio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480119/ https://www.ncbi.nlm.nih.gov/pubmed/34586561 http://dx.doi.org/10.1007/s11899-021-00647-z |
Ejemplares similares
-
Myeloproliferative neoplasms
por: Cross, Nick
Publicado: (2019) -
Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms
por: Mora, Barbara, et al.
Publicado: (2022) -
Genetic basis and molecular profiling in myeloproliferative neoplasms
por: Luque Paz, Damien, et al.
Publicado: (2023) -
Relationship between disease biology and clinical phenotype in myeloproliferative neoplasms
por: Nangalia, Jyoti
Publicado: (2019) -
MPN-433: Outcomes of COVID-19 in Hematopoietic Stem Cell Transplant Recipients: A Single-Institution, Observational Study
por: Dwabe, Sami, et al.
Publicado: (2021)